CHELSEA LEE: Open Payments
NPI 1083305916 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 28 payments from 14 companies in 2025. Trend: 2023 $330 · 2024 $459 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $175 |
| Axsome Therapeutics, Inc. | 2 | $140 |
| EMD Serono, Inc. | 3 | $80 |
| Lundbeck LLC | 2 | $62 |
| SK Life Science, Inc. | 2 | $58 |
| Eisai Inc. | 2 | $48 |
| UCB, Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $34 |
| Otter Pharmaceuticals, LLC | 1 | $32 |
| Neurelis, Inc. | 2 | $31 |
Products named: Symbravo, QULIPTA, VYEPTI, Leqembi, SYMPAZAN, VALTOCO, KISUNLA, FYCOMPA.
Industry payments across MI — which companies pay providers there.
